0001477932-16-011103.txt : 20160629
0001477932-16-011103.hdr.sgml : 20160629
20160629161252
ACCESSION NUMBER: 0001477932-16-011103
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160623
FILED AS OF DATE: 20160629
DATE AS OF CHANGE: 20160629
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Citius Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001506251
STANDARD INDUSTRIAL CLASSIFICATION: MOTOR VEHICLE PARTS & ACCESSORIES [3714]
IRS NUMBER: 273425913
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11 COMMERCE DRIVE
STREET 2: 1ST FLOOR
CITY: CRANFORD
STATE: NJ
ZIP: 07016
BUSINESS PHONE: (908) 967-6676
MAIL ADDRESS:
STREET 1: 11 COMMERCE DRIVE
STREET 2: 1ST FLOOR
CITY: CRANFORD
STATE: NJ
ZIP: 07016
FORMER COMPANY:
FORMER CONFORMED NAME: Trail One, Inc.
DATE OF NAME CHANGE: 20110314
FORMER COMPANY:
FORMER CONFORMED NAME: TrailOne, Inc.
DATE OF NAME CHANGE: 20101119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Holuka Eugene Myron
CENTRAL INDEX KEY: 0001678292
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55532
FILM NUMBER: 161738960
MAIL ADDRESS:
STREET 1: 11 COMMERCE DRIVE
STREET 2: 11TH FLOOR
CITY: CRANFORD
STATE: NJ
ZIP: 07016
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2016-06-23
0
0001506251
Citius Pharmaceuticals, Inc.
CTXR
0001678292
Holuka Eugene Myron
11 COMMERCE DRIVE
11TH FLOOR
CRANFORD
NJ
07016
1
0
0
0
Options to Purchase Common Stock
0.001
Common Stock
36212
D
Options to Purchase Common Stock
0.8
2016-06-23
4
A
0
200000
0.8
A
2026-06-23
Common Stock
200000
200000
D
On April 14, 2014 the Reporting Person was granted a ten-year option to purchase 20,000 shares of LMB common stock at an exercise price of $0.001 per share. The option vests in 1/3 increments over a three year period commencing on the first anniversary of the date of the grant, or April 14, 2014. On March 30, 2015 the Issuer entered into that certain Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, Citius LMB Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of the Issuer and Leonard-Meron Biosciences, Inc., a Delaware corporation ("LMB"). Pursuant to the Merger Agreement, the option was converted into an option to purchase 36,212 shares of the Issuer's common stock at a per share exercise price of $0.001. The option vests in 1/3 increments over a three year period with the first installment vesting on April 14, 2014.
The options vest in full on the first anniversary of the date of grant.
/s/ Erica B. Jackson, by power of attorney
2016-06-29